跳转到主要内容
搜索

早期临床

注册

最新资源

精选资源

Upcoming early clinical webinars

网络研讨会

Integrated mechanistic modeling approaches in oncology drug development

2026 年 9 月 24 日 – 10:00 AM - 10:45 AM US ET
网络研讨会

How to Choose Your First-in-Human Dose Approach

2026 年 9 月 29 日 – 10:00 - 11:00am ET
网络研讨会

Explore Smarter, Faster PK/PD with Phoenix

2026 年 9 月 29 日 – 10-11 AM ET/CET/JST

Latest early clinical blogs

在以下活动中与我们的专家会面

现场活动

Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies

2026 年 9 月 21 日 – Cambridge Innovation Center (CIC), 1 Broadway, 5th Floor, Havana Room | Cambridge, MA
会议

Redefining Every Stage of Investment (RESI) Seed to Exit

September 22 - 23, 2026 – Westin Copley Place | Boston, MA
会议

2026 ACCP Annual Meeting

September 27 - 29, 2026 – Bethesda N Marriott Hotel & Conf Ctr N Bethesda, MD

All early clinical resources

Semi-Mechanistic Joint Population Pharmacokinetic Modeling of the Novel Antituberculosis Drug Sorfequiline and Its Metabolite M3 in Healthy Volunteers

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Infectious Disease, Modeling and Simulation, Modeling and Simulation - PK/PD, Pharmacometrics, Publication

External Data Accelerator: Your standards-first team and technology for conformant vendor data

Certara Products - Pinnacle 21, Certara Services, Data Standards, Fact Sheet

Pharmacometrics Approach Group in Japan 2026​

Modeling and Simulation - PBPK, Modeling and Simulation - QSP, Conference

Beyond Simple Allometric Scaling: Why Time-Course Methods Win for First-in-Human Predictions

Modeling and Simulation - PK/PD, Blog

From PK Data to Document: An AI-Driven Daytrip with Phoenix Cloud

Certara Products - Phoenix, Modeling and Simulation - PK/PD, Webinar

From Sentence to Simulation: Bringing AI Assistance to Pharmacometrics Modeling

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, On-Demand Webinar

A glimpse into the future of model-informed drug discovery and development

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Oncology/Hematology, Pharmacometrics, Therapeutic Specialties, Publication

Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Oncology/Hematology, Pharmacometrics, Therapeutic Specialties, Publication

Why pharmacometrics automation is the foundation of modern PK/PD

Clinical Pharmacology, Modeling and Simulation - PK/PD, Blog

De-Risking Phase 3 Rheumatoid Arthritis Trials with Model-Based Meta-Analysis (MBMA)

Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - MBMA, Case Study

The five drug development questions that bring sponsors to pharmacometrics

Clinical Pharmacology, Drug Development, ICH M15, Model Informed Drug Development, Modeling and Simulation, Pharmacometrics, Blog

Beyond Trial and Error: Model-Informed Formulation Development in Practice

Certara Products - Simcyp, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Webinar
订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。


沪ICP备2022021526号
Powered by Translations.com GlobalLink Web Software